Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-inflammatory and analgesic amides: new developments.

M Palomba1, A Pau, G Boatto

  • 1Dipartimento Farmaco Chimico Tossicologico, Facoltà di Farmacia, Università di Sassari, Italy.

Archiv Der Pharmazie
|February 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

ESMO open·2026
Same author

Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2026
Same author

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

ESMO open·2025
Same author

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.

Journal of cancer policy·2025
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025
Same author

HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib.

ESMO open·2025

New N-cycloalkyl benzamides, cinnamamides, and indole-3-carboxamides show promising analgesic and anti-inflammatory effects. These compounds were evaluated for efficacy and gastrointestinal safety, with several demonstrating significant activity in preclinical models.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used but associated with gastrointestinal side effects.
  • Development of novel anti-inflammatory and analgesic agents with improved safety profiles is crucial.

Purpose of the Study:

  • To synthesize and evaluate novel substituted N-cycloalkyl benzamides, cinnamamides, and indole-3-carboxamides.
  • To assess their analgesic and anti-inflammatory activities.
  • To determine their potential for gastrointestinal irritation.

Main Methods:

  • Synthesis of a series of N-cycloalkyl benzamides, cinnamamides, and indole-3-carboxamides.
  • Evaluation of anti-inflammatory activity using the paw edema inhibition test.
  • Assessment of analgesic activity via the acetic acid writhing test.

Related Experiment Videos

  • Comparison with indomethacin as a reference drug.

    • Main Results:

    • Compounds 1k, 1b, 1h, 1j, and 1g exhibited significant dose-dependent anti-inflammatory activity.
    • Compound 5a showed the highest analgesic potency, followed by 3a, with other compounds also demonstrating notable activity.
    • Dose-dependent effects were observed for both anti-inflammatory and analgesic activities.

    Conclusions:

    • The synthesized N-cycloalkyl benzamides, cinnamamides, and indole-3-carboxamides possess significant analgesic and anti-inflammatory properties.
    • Several compounds demonstrated potent activity, suggesting potential for further development as therapeutic agents.
    • Further studies are warranted to assess their gastrointestinal safety and therapeutic index.